First test of new drug for weight and diabetes shows early promise
NCT ID NCT05814107
Summary
This was the first study in humans to test the safety and basic effects of an experimental drug called CT-996. It involved 94 overweight or obese adults, some with type 2 diabetes, to see how their bodies handled the drug and if it caused any side effects. The main goal was to determine safe dosage levels for future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Avant Santé Research Center S.A. de C.V.
San Pedro Garza García, 66260, Mexico
-
Nucleus Network Pty Ltd.
Melbourne, 3004, Australia
Conditions
Explore the condition pages connected to this study.